Member Connect

Log in

Login to your account

Username
Password *
Remember Me
Thursday, 15 September 2016 07:40

CURE OF MDR-TB

The Tuberculosis Network Clinical Trialsgroup (TBnet), an international consortium of clinicians and scientists, has proposed new treatment outcome definitions for MDR-TB. TBnet documented the management of patients with MDR-TB at 23 different sites across Europe where they found that treatment outcomes according to the definitions proposed by the WHO did not correlate to sustained culture conversion and being free of relapse in the absence of therapy. Applying the novel TBnet MDR-TB outcome criteria “cure” is reached twice as often as compared to the WHO criteria in their study.
Monday, 11 January 2016 11:14

11th TBnet Meeting

      Our 11th TBnet meeting took place on September 2nd in London, United Kingdom. Thanks a lot to our local host, Graham Bothamley! Report will follow.  
Monday, 05 January 2015 11:33

Photo Contest 2015

- closed: evaluation done -    The winner is: Jorge Mestre from Portugal with this photo:   Polypharmacy on Pulmonary Tuberculosis treatment   If one family consists of 2 adults with Pulmonary Tuberculosis and 3 children with Latent Tuberculosis, then this would result in a mandatory daily dose of 24 tablets, 2 intramuscular injections and 45.5 ml of syrup. Complying with this is assumed as a major challenge in the treatment of the disease. Besides the stigma that still brings with it, social isolation that implies obligatory use of a mask to prevent the spread, concerns about 11 and 6 years and 21 months children, plus such immense daily dosages. The permanent anguish, regarding the children's health, is often the motivation to comply with the treatment. It is desirable, that in the not too distant future, that advances, through research, will concur to minimize the number of medications needed to treat Pulmonary Tuberculosis.       2nd place: Swarupa Nagavalli (Germany)       Its all in the head! Cerebral Tuberculosis - One of the rarest forms of TB, it can be a silent killer! Until the fatal day when the first symptom of massive seizure occured, my condition could have remained undiagnosed. Normal TB diagnosis involves blood tests, X-Ray/CT/MRI of all vital organs; here is the catch, all organs except the master controller "The Brain"! Cerebral TB is an atypical, irregular form of TB, alarming to most specialists due to its rarity. Absolutely no classic symptoms, no pre-warning until the disease had spread so far and so wide. The initial CT scan showed several lesions with massive inflammation, can take several months to cure. How did the disease spread? Why could it not be diagnosed earlier and curbed? There are some questions that remains unswered. The field of medicine requires belief and patience, the past one year has thought me both.     3rd place: Dmytro Butov (Ukraine)              
Monday, 29 September 2014 09:28

TBnet Academy

  The 3rd TBnet Academy took place in Chisinau / Moldova from May 4th to 6th 2015 Deadline for application was: February 20th 2015 Application process closed. The program can be found here. Report here.          TBnet ACADEMY 2015   FREE FELLOWSHIP GRANTS     What it is about:   3 Day Tuberculosis Academy especially for residents, fellows, doctoral students and post-docs. A forum for young clinicians and researchers in the field of tuberculosis to exchange ideas and to learn from each other under expert guidance and mentorship.   Where: Chisinau, Rep. of Moldova   When: May 03 (arrival) – May 07 (Departure) 2015     The program includes:   Keynote lectures on: Collaborative TB research in Europe Emerging tuberculosis drug-resistance Pediatric tuberculosis Non-tuberculous mycobacteria infections     Reviews (provided by participants) on: Immunology Microbiology Molecular biology Epidemiology Public Health Clinical management of TB   Special features:  How to plan a research project How to get funded How to write a manuscript How to give a winning presentation Clinical pearls Hot topics on the international research agenda     Faculty:   Sofia Alexandru (Rep. of Moldova) Victor Botnaru (Rep. of Moldova) Dumitru Chesov (Rep. of Moldova) Valeriu Crudu (Rep. of Moldova) Liliana Domente (Rep. of Moldova) Josè Dominguez (Spain) Rodica Gramma (Rep. of Moldova) Lorenzo Guglielmetti (France) Constantin Iavorschi (Rep. of Moldova) Valeriu Istrati (Rep. of Moldova) Beate Kampmann (UK) Christoph Lange (Germany) Ekatarina Norok (Rep. of Moldova) Elena Romancenco (Rep. of Moldova) Morten Ruhwald (Denmark) Doina Rusu (Rep. of Moldova) Claudia Schacht (Germany) Martina Sester (Germany) Timo Ulrichs (Germany) Valentina Vilc (Rep. of Moldova) Dirk Wagner (Germany)     Coordination committee:   Prof. Rodica Gramma (USMF, Moldova) Ass. Prof. Dumitru Chesov (USMF, Moldova) Prof. Christoph Lange (Research Center Borstel, Germany) TBnet secretariate: Mrs. Cordula Ehlers (cehlers@fz-borstel.de)    
Tuesday, 08 April 2014 10:34

New SC elected

Dear TBnet members,    the elections took place during the 9th TBnet meeting in Munich on September 5th and the new vice chair is: Lorenzo Guglielmetti - WELCOME inside TBnet !!       The Steering Committee was elected for 3 years as follows:   Chair: Graham Bothamley (GB) NE London TB Network Homerton University Hospital Homerton Row E9 6SR London United Kingdom Epidemiology/Biostatistic: Laura Anderson (GB) Health Protection Agency Respiratory Diseases Department TB Section 61 Colindale Avenue NW9 5EQ London United Kingdom Diagnostics: Morton Ruhwald (Dk) Statens Serum Institut Head of Section Human Immunology Dept. Infectious disease immunology Artillerivej 5 2300 København  Denmark Clinical Tuberculosis: Christoph Lange (D) Research Center Borstel Clinical Infectous Diseases Parkallee 35 23845 Borstel Germany Microbiology: Jose Dominguez (E) Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Ctra. de Can Ruti. Cami de les escoles s/n 08916 BADALONA Spain Translational Research: Martina Sester (D) Department of Internal Medicine IV University of the Saarland Kirrberger Straße 66421 Homburg Germany Pediatric Tuberculosis: Beate Kampmann (GB) Academic Department of Paediatrics Imperial College London Norfolk Place W2 1PG London United Kingdom Nontuberculous Mycobacteria: Dirk Wagner (D) Center for Infectious Diseases & Centre for Chronic Immunodeficiency University Medical Center Freiburg Hugstetter Str. 55 79106 Freiburg Germany Treasurer: Thomas Juers (D) SHBB mbH Mommsenstraße 12 D-23843 Bad Oldesloe Germany          
Monday, 24 March 2014 15:17

New M/XDR consensus ....

New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB   New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis (TB) and extensively drug-resistant tuberculosis (TB). Published online today (24 March 2014) in the European Respiratory Journal¸ the statements mark the first time that physicians who treat patients with multidrug- and extensively drug-resistant TB have reached a consensus on important areas of patient management where scientific evidence is inconclusive. The World Health Organization (WHO) estimates that currently 450,000 new cases with MDR-TB occur each year. The majority of affected patients live in the WHO European Region. As the emergence of these forms of the disease is fairly recent, clinical evidence is lacking and could be for many years to come. To help bridge this gap in knowledge, experts from the European-based TBNET network have provided harmonised answers to the key questions for the prevention, diagnosis, treatment and management of multidrug- and extensively drug-resistant TB.   Read more.... Read full article here.
Saturday, 29 June 2013 17:52

Test

test
Sunday, 16 June 2013 16:42

NEW TBnet WEBPAGE

The new TBnet-webpage has been created mostly by S. Seesemann (www.cmstyles.de), a highly recommendable professional webdesigner, with help of Eurice, who provided the layout. Many, many thanks!!
Friday, 31 May 2013 21:39

Test Capture 6

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.